Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs1693484 | chr17:39337846 | C/T | 6.24E-7 | 134 | 42.18 | 46.03 | 13.17 | KM Plot |
| TGCT | rs16963425 | chr19:30340724 | G/A | 2.84E-6 | 130 | 37.3 | 54.18 | 20.6 | KM Plot |
| TGCT | rs16963431 | chr19:30344536 | C/T | 3.86E-6 | 128 | 37.2 | 51.67 | 20.6 | KM Plot |
| TGCT | rs16966703 | chr17:39502398 | A/G | 8.47E-7 | 131 | 45.83 | 33.87 | 13.17 | KM Plot |
| TGCT | rs17004630 | chr21:45508561 | A/G | 1.42E-9 | 134 | 12.03 | 49.93 | 40.57 | KM Plot |
| TGCT | rs170277 | chr6:105538806 | G/A | 1.83E-5 | 133 | 20.42 | 37.3 | 42.18 | KM Plot |
| TGCT | rs17039656 | chr9:137942956 | A/G | 3.57E-7 | 134 | 17.28 | 42.1 | 42.27 | KM Plot |
| TGCT | rs17042843 | chr12:77466341 | C/T | 0 | 134 | 0.57 | 51.67 | 39.38 | KM Plot |
| TGCT | rs17087692 | chr6:156979025 | G/A | 0.000105 | 133 | 39.38 | 88.17 | 59.27 | KM Plot |
| TGCT | rs17087694 | chr6:156979348 | A/T | 0.000105 | 133 | 39.38 | 88.17 | 59.27 | KM Plot |
| TGCT | rs17087699 | chr6:156979600 | C/T | 0.000105 | 133 | 39.38 | 88.17 | 59.27 | KM Plot |
| TGCT | rs17087720 | chr6:157021745 | G/C | 0.000123 | 132 | 38.2 | 68.97 | 59.27 | KM Plot |
| TGCT | rs17152978 | chr8:11044927 | C/T | 1.13E-13 | 134 | 17.1 | 37.3 | 42.18 | KM Plot |
| TGCT | rs17155886 | chr10:1145182 | A/G | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs17222141 | chr8:20028895 | G/T | 3.48E-12 | 132 | 42.27 | 41.47 | 20.6 | KM Plot |